Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Experimental: YZJ-4729

Phase 3Small molecule

SShanghai Haiyan Pharmaceutical Technology Co., Ltd.

1

Indications

1

Total Trials

1

Active Trials

0

Competitors

Clinical

Trials by Indication[1]

Pain1 trial

A Phase Ⅲ, Randomized, Double-Blind, Placebo- and Active-controlled Study of YZJ-4729 Tartrate Injection for the Treatment of Moderate to Severe Pain After Abdominal Surgery

Active, not recruiting·SShanghai Haiyan Pharmaceutical Technology Co., Ltd.·Phase 3·NCT06890533·560 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Experimental: YZJ-4729. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Experimental: YZJ-4729 compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Experimental: YZJ-4729. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Shanghai Haiyan Pharmaceutical Technology Co., Ltd. company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 3[1]
Company: SShanghai Haiyan Pharmaceutical Technology Co., Ltd.

Related News